Cash flow Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 04:35:04 13/03/2026 pm IST			5-day change	1st Jan Change
2,138.90 ^INR	-3.13%		-2.20%	-2.62%

27/02	Mankind Pharma says tax penalty of 10.2 million rupees dropped	RE
16/02	Mankind Pharma says tax penalty of 4.6 million rupees dropped	RE

d3d34ff8e83e26a20f74db776da2e0ca.n-808LBtKYnBvLK3KR09HZDzWbYSYrt5vTPl6Y6Pp4s.rptWgOgMTsyl-t_9U0pRWNGLNv96Eo0y5AOdgeH24N-tln6D1xtavoX9-w

Published financial data: MANKIND PHARMA LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	6.22TCr	7.78TCr	8.75TCr	10TCr	12TCr
Total Revenues	6.22TCr	7.78TCr	8.75TCr	10TCr	12TCr
Cost of Goods Sold, Total	1.85TCr	2.49TCr	3TCr	3.32TCr	3.66TCr
Gross Profit	4.38TCr	5.29TCr	5.75TCr	7.01TCr	8.55TCr
Selling General & Admin Expenses, Total	1.81TCr	2.09TCr	2.31TCr	2.9TCr	3.47TCr
Depreciation & Amortization - (IS)	118.97Cr	166.62Cr	325.92Cr	398.25Cr	621.22Cr
Other Operating Expenses	860.39Cr	1.16TCr	1.52TCr	1.56TCr	2.05TCr
Other Operating Expenses, Total	2.79TCr	3.42TCr	4.16TCr	4.86TCr	6.14TCr
Operating Income	1.59TCr	1.88TCr	1.59TCr	2.15TCr	2.41TCr
Interest Expense, Total	-19Cr	-56Cr	-40Cr	-29Cr	-420.89Cr
Interest And Investment Income	39Cr	13Cr	13Cr	40Cr	68Cr
Net Interest Expenses	19Cr	-43Cr	-28Cr	11Cr	-352.98Cr
Income (Loss) On Equity Invest.	12Cr	14Cr	12Cr	15Cr	12Cr
Currency Exchange Gains (Loss)	50.24L	8.84Cr	10Cr	8.64Cr	20Cr
Other Non Operating Income (Expenses)	5.06Cr	3.31Cr	54Cr	88Cr	111.47Cr
EBT, Excl. Unusual Items	1.63TCr	1.86TCr	1.64TCr	2.27TCr	2.2TCr
Impairment of Goodwill	-	-	-3.85Cr	-	-
Gain (Loss) On Sale Of Investments	63Cr	112.95Cr	37Cr	129.53Cr	160.84Cr
Gain (Loss) On Sale Of Assets	-3.04Cr	-3.74Cr	1.66Cr	48.01L	161.35Cr
Asset Writedown	-3.89Cr	-5.76Cr	-9.71Cr	-9.16Cr	-5.02Cr
Insurance Settlements	93.68L	1.36Cr	4.31Cr	1.07Cr	97L
Other Unusual Items	7.71Cr	8.53Cr	4.15Cr	2.48Cr	81L
EBT, Incl. Unusual Items	1.69TCr	1.97TCr	1.67TCr	2.4TCr	2.52TCr
Income Tax Expense	398.58Cr	521.64Cr	361.56Cr	457.59Cr	509.74Cr
Earnings From Continuing Operations	1.29TCr	1.45TCr	1.31TCr	1.94TCr	2.01TCr
Earnings Of Discontinued Operations	-	-	-	-	4.53Cr
Net Income to Company	1.29TCr	1.45TCr	1.31TCr	1.94TCr	2.01TCr
Minority Interest	-28Cr	-19Cr	-28Cr	-29Cr	-20Cr
Net Income - (IS)	1.27TCr	1.43TCr	1.28TCr	1.91TCr	1.99TCr
Net Income to Common Incl Extra Items	1.27TCr	1.43TCr	1.28TCr	1.91TCr	1.99TCr
Net Income to Common Excl. Extra Items	1.27TCr	1.43TCr	1.28TCr	1.91TCr	1.99TCr
Per Share Items
Net EPS - Basic	31.59	35.78	32	47.75	49.28
Basic EPS - Continuing Operations	31.59	35.78	32	47.75	49.17
Basic Weighted Average Shares Outstanding	40Cr	40Cr	40Cr	40Cr	40Cr
Net EPS - Diluted	31.59	35.78	32	47.68	49.19
Diluted EPS - Continuing Operations	31.59	35.78	32	47.68	49.08
Diluted Weighted Average Shares Outstanding	40Cr	40Cr	40Cr	40Cr	40Cr
Normalized Basic EPS	24.7	28.55	24.85	34.77	33.5
Normalized Diluted EPS	24.7	28.55	24.85	34.72	33.44
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	1.7TCr	2.04TCr	1.91TCr	2.54TCr	2.99TCr
EBITA	1.6TCr	1.9TCr	1.74TCr	2.31TCr	2.74TCr
EBIT	1.59TCr	1.88TCr	1.59TCr	2.15TCr	2.41TCr
EBITDAR	1.72TCr	2.06TCr	1.93TCr	2.56TCr	3.02TCr
Total Revenues (As Reported)	6.39TCr	7.98TCr	8.88TCr	11TCr	13TCr
Effective Tax Rate - (Ratio)	23.56	26.42	21.63	19.07	20.26
Total Current Taxes	394.74Cr	469.03Cr	327.56Cr	492.58Cr	596.04Cr
Total Deferred Taxes	2.42Cr	53Cr	34Cr	-35Cr	-86Cr
Normalized Net Income	989.29Cr	1.14TCr	995.46Cr	1.39TCr	1.35TCr
Interest on Long-Term Debt	32.71L	47.95L	44.92L	78.51L	1.43Cr
Non-Cash Pension Expense	3.78Cr	4.12Cr	5.23Cr	6.56Cr	14Cr
Supplemental Operating Expense Items
Advertising Expense	373.38Cr	451.57Cr	373.67Cr	603.89Cr	755.36Cr
Selling and Marketing Expenses	373.38Cr	451.57Cr	373.67Cr	603.89Cr	755.36Cr
Research And Development Expense From Footnotes	12Cr	-	25Cr	25Cr	25Cr
Net Rental Expense, Total	18Cr	21Cr	20Cr	23Cr	26Cr
Imputed Operating Lease Interest Expense	13Cr	16Cr	12Cr	28Cr	20Cr
Imputed Operating Lease Depreciation	4.57Cr	4.95Cr	7.94Cr	-4.92Cr	5.84Cr
Maintenance & Repair Expenses, Total	49Cr	66Cr	89Cr	111.03Cr	170.53Cr
Stock-Based Comp., SG&A Exp. (Total)	-	-	6L	23Cr	27Cr
Total Stock-Based Compensation	-	-	6L	23Cr	27Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	167.18Cr	302.53Cr	304.82Cr	382.01Cr	407.36Cr
Short Term Investments	533.56Cr	102.31Cr	141.31Cr	746.38Cr	426.6Cr
Trading Asset Securities, Total	1.31TCr	861.47Cr	1.08TCr	2.26TCr	1.69TCr
Total Cash And Short Term Investments	2.01TCr	1.27TCr	1.52TCr	3.39TCr	2.52TCr
Accounts Receivable, Total	330.61Cr	388.17Cr	576.42Cr	848.28Cr	1.54TCr
Other Receivables	69Cr	35Cr	32Cr	44Cr	46Cr
Notes Receivable	18Cr	1.19Cr	1.63Cr	2.86Cr	3.95Cr
Total Receivables	418.3Cr	423.99Cr	610.16Cr	894.96Cr	1.59TCr
Inventory	1.18TCr	1.76TCr	1.5TCr	1.55TCr	2.09TCr
Prepaid Expenses	37Cr	136.01Cr	33Cr	60Cr	61Cr
Other Current Assets, Total	260.94Cr	820.27Cr	664.49Cr	672.92Cr	720.22Cr
Total Current Assets	3.91TCr	4.41TCr	4.33TCr	6.57TCr	6.99TCr
Gross Property Plant And Equipment	2.44TCr	2.97TCr	3.76TCr	4.1TCr	4.38TCr
Accumulated Depreciation	-444.77Cr	-582.24Cr	-743.73Cr	-963.39Cr	-1.16TCr
Net Property Plant And Equipment	1.99TCr	2.39TCr	3.02TCr	3.14TCr	3.21TCr
Long-term Investments	209.73Cr	240.39Cr	357.76Cr	311.06Cr	484.81Cr
Goodwill	20Cr	20Cr	20Cr	20Cr	6.49TCr
Other Intangibles, Total	19Cr	1.87TCr	1.76TCr	1.66TCr	10TCr
Loans Receivable Long-Term	7L	3L	-	-	-
Deferred Tax Assets Long-Term	49Cr	39Cr	30Cr	80Cr	107.89Cr
Other Long-Term Assets, Total	176.28Cr	176.97Cr	204.61Cr	181.82Cr	348.41Cr
Total Assets	6.37TCr	9.15TCr	9.72TCr	12TCr	28TCr
Liabilities
Accounts Payable, Total	666.96Cr	1.08TCr	1.01TCr	1.1TCr	1.13TCr
Accrued Expenses, Total	128.67Cr	259.77Cr	171.02Cr	222.78Cr	781.24Cr
Short-term Borrowings	197.55Cr	805.15Cr	115.02Cr	151.47Cr	2.7TCr
Current Portion of Long-Term Debt	19Cr	24Cr	24Cr	20Cr	261.14Cr
Current Portion of Leases	1.62Cr	2.06Cr	2.56Cr	3.42Cr	14Cr
Current Income Taxes Payable	11Cr	15Cr	46Cr	46Cr	18Cr
Unearned Revenue Current, Total	14Cr	19Cr	166.23Cr	185.85Cr	194.03Cr
Other Current Liabilities	315.24Cr	421.37Cr	329.4Cr	387.13Cr	565.58Cr
Total Current Liabilities	1.35TCr	2.62TCr	1.86TCr	2.12TCr	5.66TCr
Long-Term Debt	57Cr	49Cr	23Cr	25Cr	5.53TCr
Long-Term Leases	4.51Cr	2.99Cr	5.18Cr	7.71Cr	14Cr
Unearned Revenue Non Current	7.89Cr	20Cr	25Cr	23Cr	20Cr
Pension & Other Post Retirement Benefits	72Cr	80Cr	98Cr	123.12Cr	155.06Cr
Deferred Tax Liability Non Current	13Cr	56Cr	77Cr	89Cr	1.81TCr
Other Non Current Liabilities	1Cr	-	-	-	-
Total Liabilities	1.51TCr	2.83TCr	2.09TCr	2.39TCr	13TCr
Common Stock, Total	40Cr	40Cr	40Cr	40Cr	41Cr
Additional Paid In Capital	42Cr	42Cr	42Cr	42Cr	3.01TCr
Retained Earnings	5.54TCr	6.97TCr	8.25TCr	10TCr	12TCr
Comprehensive Income and Other	-901.42Cr	-899.87Cr	-896.9Cr	-875.67Cr	-861.47Cr
Total Common Equity	4.72TCr	6.16TCr	7.44TCr	9.36TCr	14TCr
Minority Interest	140.89Cr	161.08Cr	188.07Cr	212.7Cr	235.79Cr
Total Equity	4.86TCr	6.32TCr	7.62TCr	9.58TCr	15TCr
Total Liabilities And Equity	6.37TCr	9.15TCr	9.72TCr	12TCr	28TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	40Cr	40Cr	40Cr	40Cr	41Cr
ECS Total Common Shares Outstanding	40Cr	40Cr	40Cr	40Cr	41Cr
Book Value / Share	117.88	153.65	185.61	233.73	347.39
Tangible Book Value	4.68TCr	4.26TCr	5.66TCr	7.68TCr	-2.28TCr
Tangible Book Value Per Share	116.9	106.36	141.21	191.72	-55.35
Total Debt	279.61Cr	883.64Cr	170.37Cr	207.17Cr	8.51TCr
Net Debt	-1.73TCr	-382.68Cr	-1.35TCr	-3.18TCr	5.99TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	73Cr	81Cr	99Cr	124.03Cr	285.39Cr
Debt Equivalent Oper. Leases	143.48Cr	170.06Cr	163.41Cr	185.7Cr	205.44Cr
Minority Interest, Total (Incl. Fin. Div)	140.89Cr	161.08Cr	188.07Cr	212.7Cr	235.79Cr
Equity Method Investments, Total	165.79Cr	167.74Cr	181.41Cr	189.28Cr	190.9Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	284.47Cr	399.81Cr	417.08Cr	410.76Cr	551.83Cr
Inventories - Work In Process, Total	73Cr	94Cr	86Cr	100Cr	186.08Cr
Inventories - Finished Goods, Total	771.43Cr	1.2TCr	919.76Cr	1TCr	1.31TCr
Inventories - Others	54Cr	66Cr	76Cr	42Cr	46Cr
Land - (BS)	241.42Cr	243.48Cr	352.79Cr	352.99Cr	380.09Cr
Buildings, Total	575.01Cr	586.27Cr	1.05TCr	1.25TCr	1.04TCr
Machinery, Total	1.18TCr	1.39TCr	1.74TCr	2.15TCr	2.45TCr
Full Time Employees	17.4T	-	18.47T	19.54T	19.62T
Accumulated Allowance for Doubtful Accounts (Supple)	4.47Cr	11Cr	20Cr	28Cr	61Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	1.27TCr	1.43TCr	1.28TCr	1.91TCr	1.99TCr
Depreciation & Amortization - CF	104.88Cr	141.4Cr	167.08Cr	235.87Cr	258.93Cr
Amortization of Goodwill and Intangible Assets - (CF)	11Cr	20Cr	153.73Cr	153.65Cr	335.07Cr
Depreciation & Amortization, Total	115.44Cr	161.64Cr	320.81Cr	389.52Cr	594Cr
Amortization of Deferred Charges, Total - (CF)	3.53Cr	4.98Cr	5.11Cr	8.73Cr	27Cr
(Gain) Loss From Sale Of Asset	3.04Cr	3.74Cr	-1.66Cr	-48.01L	-161.35Cr
(Gain) Loss on Sale of Investments - (CF)	-45Cr	-104.95Cr	-37Cr	-133.53Cr	-160.84Cr
Asset Writedown & Restructuring Costs	-	-2.24Cr	14Cr	9.16Cr	4.35Cr
Provision for Credit Losses	1.49Cr	3.03Cr	1.94Cr	4Cr	-
(Income) Loss On Equity Investments - (CF)	-12Cr	-14Cr	-12Cr	-15Cr	-12Cr
Stock-Based Compensation (CF)	-	-	6L	23Cr	27Cr
Provision and Write-off of Bad Debts	75.41L	12Cr	14Cr	14Cr	14Cr
Net Cash From Discontinued Operations	-	-	-	-	8.45Cr
Other Operating Activities, Total	-98Cr	9.12Cr	61Cr	-80Cr	229Cr
Change In Accounts Receivable	198.87Cr	-66Cr	-205.31Cr	-289.91Cr	-123.55Cr
Change In Inventories	-284.4Cr	-576.7Cr	261.78Cr	-55Cr	-220.7Cr
Change In Accounts Payable	-78Cr	419.85Cr	-65Cr	97Cr	-146.04Cr
Change in Other Net Operating Assets	99Cr	-363.32Cr	175.28Cr	267.88Cr	343.87Cr
Cash from Operations	1.17TCr	919.78Cr	1.81TCr	2.15TCr	2.41TCr
Capital Expenditure	-308.43Cr	-464.86Cr	-789.02Cr	-315.33Cr	-460.79Cr
Sale of Property, Plant, and Equipment	74.25L	3.15Cr	6.05Cr	7.51Cr	12Cr
Cash Acquisitions	-	-	-3.83Cr	-	-14TCr
Divestitures	-	-	-	-	562.46Cr
Sale (Purchase) of Real Estate properties	-	-	-	-	7.99Cr
Sale (Purchase) of Intangible assets	-	-1.88TCr	-43Cr	-67Cr	-59Cr
Investment in Marketable and Equity Securities, Total	-947.76Cr	943.04Cr	-236.64Cr	-1.74TCr	901.26Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-31.86L	-10L	-40.94L	-	-
Other Investing Activities, Total	37Cr	30Cr	13Cr	32Cr	47Cr
Cash from Investing	-1.22TCr	-1.37TCr	-1.05TCr	-2.08TCr	-13TCr
Short Term Debt Issued, Total	126.78Cr	1.27TCr	1.09TCr	374.61Cr	6.56TCr
Long-Term Debt Issued, Total	452.16Cr	5.86Cr	3.85Cr	26Cr	5.89TCr
Total Debt Issued	578.94Cr	1.28TCr	1.1TCr	400.7Cr	12TCr
Short Term Debt Repaid, Total	-12Cr	-645.35Cr	-1.76TCr	-339.81Cr	-4.48TCr
Long-Term Debt Repaid, Total	-460.32Cr	-10Cr	-32Cr	-29Cr	-603.89Cr
Total Debt Repaid	-472.78Cr	-655.78Cr	-1.8TCr	-369.27Cr	-5.08TCr
Issuance of Common Stock	-	-	-	-	2.96TCr
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-17Cr	-18Cr	-42Cr	-26Cr	-98Cr
Cash from Financing	89Cr	604.62Cr	-739.73Cr	5.27Cr	10TCr
Foreign Exchange Rate Adjustments	37.52L	47.79L	2.32Cr	1.17Cr	1.31Cr
Miscellaneous Cash Flow Adjustments	-100.06Cr	1T	-	-	67Cr
Net Change in Cash	-59Cr	155.73Cr	22Cr	77Cr	22Cr
Supplemental Items
Cash Interest Paid	17Cr	18Cr	42Cr	26Cr	98Cr
Cash Income Tax Paid (Refund)	454.08Cr	499.51Cr	323.1Cr	479.53Cr	566.75Cr
Levered Free Cash Flow	587.71Cr	-1.62TCr	711.74Cr	1.21TCr	764.99Cr
Unlevered Free Cash Flow	599.73Cr	-1.59TCr	736.91Cr	1.23TCr	1.03TCr
Change In Net Working Capital	204.75Cr	582.3Cr	-250.32Cr	151.41Cr	604.14Cr
Net Debt Issued / Repaid	106.16Cr	622.41Cr	-697.8Cr	31Cr	7.37TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	17.37	15.12	10.52	12.41	7.57
Return on Total Capital	22.22	19.01	13.24	15.3	9.16
Return On Equity %	30.3	25.99	18.79	22.58	16.62
Return on Common Equity	30.84	26.36	18.86	22.77	16.77
Margin Analysis
Gross Profit Margin %	70.32	68.03	65.68	67.87	70.02
SG&A Margin	29.03	26.9	26.43	28.08	28.45
EBITDA Margin %	27.38	26.17	21.77	24.54	24.49
EBITA Margin %	25.72	24.39	19.91	22.31	22.46
EBIT Margin %	25.55	24.13	18.15	20.82	19.72
Income From Continuing Operations Margin %	20.78	18.67	14.97	18.79	16.44
Net Income Margin %	20.33	18.42	14.65	18.51	16.31
Net Avail. For Common Margin %	20.33	18.42	14.65	18.51	16.27
Normalized Net Income Margin	15.89	14.7	11.38	13.48	11.08
Levered Free Cash Flow Margin	9.44	-20.85	8.13	11.75	6.27
Unlevered Free Cash Flow Margin	9.64	-20.4	8.42	11.93	8.42
Asset Turnover
Asset Turnover	1.09	1	0.93	0.95	0.61
Fixed Assets Turnover	3.23	3.55	3.24	3.36	3.84
Receivables Turnover (Average Receivables)	14.45	21.65	18.14	14.51	10.23
Inventory Turnover (Average Inventory)	1.77	1.69	1.84	2.18	2.01
Short Term Liquidity
Current Ratio	2.89	1.68	2.32	3.1	1.23
Quick Ratio	1.78	0.64	1.14	2.02	0.73
Operating Cash Flow to Current Liabilities	0.86	0.35	0.97	1.02	0.43
Days Sales Outstanding (Average Receivables)	25.27	16.86	20.12	25.23	35.68
Days Outstanding Inventory (Average Inventory)	205.77	215.94	198.03	168.19	181.88
Average Days Payable Outstanding	120.9	103.82	138.78	114.45	83.02
Cash Conversion Cycle (Average Days)	110.14	128.98	79.37	78.97	134.54
Long Term Solvency
Total Debt/Equity	5.75	13.99	2.23	2.16	58.42
Total Debt / Total Capital	5.44	12.27	2.19	2.12	36.88
LT Debt/Equity	1.27	0.83	0.37	0.34	38.03
Long-Term Debt / Total Capital	1.2	0.72	0.36	0.33	24
Total Liabilities / Total Assets	23.69	30.95	21.53	19.96	47.52
EBIT / Interest Expense	82.67	33.66	39.44	75.24	5.72
EBITDA / Interest Expense	88.67	36.56	47.4	88.86	7.13
(EBITDA - Capex) / Interest Expense	72.64	28.22	27.81	77.83	6.04
Total Debt / EBITDA	0.16	0.43	0.09	0.08	2.84
Net Debt / EBITDA	-1.01	-0.19	-0.71	-1.25	1.99
Total Debt / (EBITDA - Capex)	0.2	0.56	0.15	0.09	3.35
Net Debt / (EBITDA - Capex)	-1.24	-0.24	-1.21	-1.43	2.36
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6	25.22	12.44	18.12	18.98
Gross Profit, 1 Yr. Growth %	10.8	21.21	8.55	22.06	22.9
EBITDA, 1 Yr. Growth %	8.84	19.51	-4.31	33.15	18.87
EBITA, 1 Yr. Growth %	8.45	18.55	-5.96	32.34	19.02
EBIT, 1 Yr. Growth %	8.14	18.06	-13.32	35.48	11.95
Earnings From Cont. Operations, 1 Yr. Growth %	22.43	12.37	-9.86	48.26	3.39
Net Income, 1 Yr. Growth %	22.81	13.28	-10.58	49.23	4.08
Normalized Net Income, 1 Yr. Growth %	9.88	15.62	-12.97	39.93	-2.79
Diluted EPS Before Extra, 1 Yr. Growth %	22.82	13.27	-10.57	49	2.98
Accounts Receivable, 1 Yr. Growth %	-37.75	17.41	48.5	47.16	81.35
Inventory, 1 Yr. Growth %	31.63	48.73	-14.87	3.67	34.78
Net Property, Plant and Equip., 1 Yr. Growth %	6.82	19.98	26.26	4.03	2.4
Total Assets, 1 Yr. Growth %	25.61	43.55	6.21	23.14	132.04
Tangible Book Value, 1 Yr. Growth %	36.17	-9.02	32.77	35.77	-129.74
Common Equity, 1 Yr. Growth %	35.48	30.35	20.8	25.93	53.07
Cash From Operations, 1 Yr. Growth %	9.1	-19.12	97.15	18.7	12.12
Capital Expenditures, 1 Yr. Growth %	35.29	52.21	69.73	-60.03	46.13
Levered Free Cash Flow, 1 Yr. Growth %	-21.91	-379.11	-143.45	70.67	-39.48
Unlevered Free Cash Flow, 1 Yr. Growth %	-21.71	-367.56	-145.97	67.26	-19.77
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.79	15.12	18.66	15.24	18.12
Gross Profit, 2 Yr. CAGR %	16.44	15.77	14.71	15.11	21.96
EBITDA, 2 Yr. CAGR %	34.95	14.05	5.74	12.87	25.27
EBITA, 2 Yr. CAGR %	35.65	13.39	4.32	11.56	25.46
EBIT, 2 Yr. CAGR %	35.24	12.99	-0.06	8.37	23.11
Earnings From Cont. Operations, 2 Yr. CAGR %	45.54	17.29	0.64	15.6	23.78
Net Income, 2 Yr. CAGR %	47.9	17.95	0.65	15.52	24.63
Normalized Net Income, 2 Yr. CAGR %	41.15	12.72	0.31	10.36	16.59
Diluted EPS Before Extra, 2 Yr. CAGR %	47.91	17.95	0.65	15.44	23.85
Accounts Receivable, 2 Yr. CAGR %	22.53	-14.51	32.04	47.83	63.36
Inventory, 2 Yr. CAGR %	20.07	39.92	12.52	-6.06	18.2
Net Property, Plant and Equip., 2 Yr. CAGR %	8.92	13.21	23.08	14.61	3.21
Total Assets, 2 Yr. CAGR %	24.48	34.28	23.47	14.36	69.03
Tangible Book Value, 2 Yr. CAGR %	29.91	11.31	9.91	34.26	-36.46
Common Equity, 2 Yr. CAGR %	29.33	32.89	25.48	23.34	38.84
Cash From Operations, 2 Yr. CAGR %	39.58	-7.38	26.27	52.98	15.37
Capital Expenditures, 2 Yr. CAGR %	1.79	42.8	60.73	-17.64	-23.58
Levered Free Cash Flow, 2 Yr. CAGR %	-	46.83	10.65	-13.88	3.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	43.96	11.44	-12.31	18.11
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	16.04	14.22	18.48	16.19
Gross Profit, 3 Yr. CAGR %	-	17.92	13.31	17.11	17.32
EBITDA, 3 Yr. CAGR %	-	29.59	6.77	14.19	14.51
EBITA, 3 Yr. CAGR %	-	29.69	5.68	12.93	13.97
EBIT, 3 Yr. CAGR %	-	29.26	2.6	10.6	9.52
Earnings From Cont. Operations, 3 Yr. CAGR %	-	33.51	7.44	14.52	11.36
Net Income, 3 Yr. CAGR %	-	35.32	7.55	14.77	11.57
Normalized Net Income, 3 Yr. CAGR %	-	32.07	3.41	12.08	5.76
Diluted EPS Before Extra, 3 Yr. CAGR %	-	35.32	7.55	14.71	11.11
Accounts Receivable, 3 Yr. CAGR %	-	20.8	2.77	36.9	58.25
Inventory, 3 Yr. CAGR %	-	28.95	18.56	9.49	5.95
Net Property, Plant and Equip., 3 Yr. CAGR %	-	12.49	17.4	16.37	10.38
Total Assets, 3 Yr. CAGR %	-	30.54	24.18	23.36	44.78
Tangible Book Value, 3 Yr. CAGR %	-	15.37	18.05	17.93	-18.77
Common Equity, 3 Yr. CAGR %	-	29.67	28.73	25.63	32.54
Cash From Operations, 3 Yr. CAGR %	-	15.28	19.14	23.7	37.93
Capital Expenditures, 3 Yr. CAGR %	-	16.02	51.26	1.07	-0.29
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-1.84	27.84	-22.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-1.29	27.59	-13.76
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	15.72	15.76
Gross Profit, 5 Yr. CAGR %	-	-	-	16.79	16.7
EBITDA, 5 Yr. CAGR %	-	-	-	22.08	13.82
EBITA, 5 Yr. CAGR %	-	-	-	21.52	13.19
EBIT, 5 Yr. CAGR %	-	-	-	19.87	10.36
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	26.04	13.7
Net Income, 5 Yr. CAGR %	-	-	-	27.02	14.08
Normalized Net Income, 5 Yr. CAGR %	-	-	-	22.91	8.49
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	26.99	13.8
Accounts Receivable, 5 Yr. CAGR %	-	-	-	30.96	23.7
Inventory, 5 Yr. CAGR %	-	-	-	13.6	18.42
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	13.33	11.5
Total Assets, 5 Yr. CAGR %	-	-	-	23.81	40.48
Tangible Book Value, 5 Yr. CAGR %	-	-	-	22.58	-7.86
Common Equity, 5 Yr. CAGR %	-	-	-	27.1	32.68
Cash From Operations, 5 Yr. CAGR %	-	-	-	29.09	17.62
Capital Expenditures, 5 Yr. CAGR %	-	-	-	1.16	15.11
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	0.33
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	6.06